As patient safety takes centre stage in an increasingly complex healthcare environment, the demand for resilient and forward-looking drug safety practices has never been greater. Responding to this urgent need, Eminence Group returns with the 4th Edition of the Drug Safety Symposium (DSS) – India Chapter, scheduled for June 25–26, 2025, in Mumbai.
Following successful editions in India and Dubai, DSS has evolved from a knowledge-sharing initiative into a premier, solutions-driven platform where the region’s top pharmacovigilance (PV), regulatory affairs, clinical safety, QA, and MAH professionals collaborate to shape the future of patient safety.
2025 Theme: ‘Beyond Compliance – Creating a Future-Ready, Globally Aligned PV Ecosystem’
This year’s theme underscores the need to go beyond baseline regulatory expectations. It calls for a proactive, globally harmonized approach to PV—one that adapts to changing risk profiles, technological shifts, and the expanding scope of real-world evidence.
Why DSS 2025 Stands Out
Hands-On Learning That Translates Into Action
DSS 2025 is all about practical value. Attendees will gain direct access to interactive workshops and expert-led training sessions covering:
- IDMP Transitions & Compliance Readiness
- AI in Signal Detection: Boundaries & Opportunities
- Inspection Trends in Emerging Markets (Peru, Mexico, Ukraine)
- CSV Documentation and PSMF Integration across geographies like the UK, EU, and India
- Live demos and deep-dive case studies will help participants return with immediately actionable insights.
Real Conversations in Open Forums
Forget staged panels and scripted Q&As. DSS 2025 introduces no-barrier discussion zones, where industry leaders openly address pressing challenges like:
- QPPV Process Optimization
- REMS Implementation in Rest-of-World Markets
- Retention and Upskilling in an Evolving PV Talent Landscape
- Expect candid dialogue, shared problem-solving, and practical takeaways—not just theory.
Multi-Stakeholder Collaboration at Its Core
DSS 2025 brings together voices from across the pharma ecosystem—including regulators, industry experts, and innovative service providers—to explore complex, future-forward topics such as:
- Biosimilar and Vaccine Safety Guidelines
- The Rise of Global Capability Centers (GCCs)
- Digitalization of PV Operations
This is where silos dissolve, and new cross-functional alliances are born.
Curated, Stakeholder-Driven Topics
Attendees can expect deep dives into:
- XEVMPD to IDMP Transition: Key Implications for Indian PV Teams
- AI in Signal Management: What Still Needs Human Oversight
- PSMF Integration Across Geographies: Strategies for Unified Compliance
- Leveraging Real-World Evidence (RWE) for Regulatory Decision-Making
- Effective Vendor & Stakeholder Management in Complex PV Ecosystems
- Building and Retaining the PV Workforce of the Future
More Than a Symposium—A Strategic Movement
DSS is no longer just an event—it’s a growing community of change-makers. It’s where roles and departments blend into a shared purpose: protecting patients, advancing innovation, and building a globally resilient pharmacovigilance culture.
Save the Dates: June 25–26, 2025 | Mumbai
Join in Mumbai for two days of clarity, candor, and collaboration, to co-create the next chapter of global drug safety—together.
